Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-16

Clinical Trial Update: Paclitaxel (Albumin Bound),Bleomycin And Cisplatin Or Carboplatin for Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating paclitaxel (albumin-bound) with bleomycin and cisplatin or carboplatin for recurrent or metastatic squamous cell carcinoma …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bleomycin (bleomycin)
  • CARBOPLATIN (Carboplatin)
  • CISPLATIN (cisplatin)
  • Paclitaxel (albumin-bound) (paclitaxel albumin-bound)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Squamous Cell Carcinoma Of The Head And Neck | Phase 2 | Status: UNKNOWN